Jean-Francois Jasmin, Ph.D. - Publications

Affiliations: 
2004 Université de Montréal, Montréal, Canada 
Area:
Animal Physiology Biology, Molecular Biology

38 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Chi Y, Jasmin JF, Seki Y, Lisanti MP, Charron MJ, Lefer DJ, Schuster VL. Inhibition of the Prostaglandin Transporter PGT Lowers Blood Pressure in Hypertensive Rats and Mice. Plos One. 10: e0131735. PMID 26121580 DOI: 10.1371/journal.pone.0131735  0.36
2015 Chabot A, Meus MA, Naud P, Hertig V, Dupuis J, Villeneuve L, El Khoury N, Fiset C, Nattel S, Jasmin JF, Calderone A. Nestin is a marker of lung remodeling secondary to myocardial infarction and type I diabetes in the rat. Journal of Cellular Physiology. 230: 170-9. PMID 24915827 DOI: 10.1002/jcp.24696  0.36
2014 Liu Y, Zhang J, Yi B, Chen M, Qi J, Yin Y, Lu X, Jasmin JF, Sun J. Nur77 suppresses pulmonary artery smooth muscle cell proliferation through Inhibition of the STAT3/Pim-1/NFAT pathway American Journal of Respiratory Cell and Molecular Biology. 50: 379-388. PMID 24047441 DOI: 10.1165/rcmb.2013-0198OC  0.36
2013 De Almeida CJG, Jasmin JF, Del Galdo F, Lisanti MP. Genetic ablation of caveolin-2 sensitizes mice to bleomycin-induced injury Cell Cycle. 12: 2248-2254. PMID 24067367 DOI: 10.4161/cc.25335  0.36
2013 Addabbo F, Chen Q, Patel DP, Rabadi M, Ratliff B, Zhang F, Jasmin JF, Wolin M, Lisanti M, Gross SS, Goligorsky MS. Glutamine supplementation alleviates vasculopathy and corrects metabolic profile in an in vivo model of endothelial cell dysfunction. Plos One. 8: e65458. PMID 23776484 DOI: 10.1371/journal.pone.0065458  0.36
2013 Quann K, Gonzales DM, Mercier I, Wang C, Sotgia F, Pestell RG, Lisanti MP, Jasmin JF. Caveolin-1 is a negative regulator of tumor growth in glioblastoma and modulates chemosensitivity to temozolomide Cell Cycle. 12: 1510-1520. PMID 23598719 DOI: 10.4161/cc.24497  0.36
2013 El-Helou V, Chabot A, Gosselin H, Villeneuve L, Clavet-Lanthier ME, Tanguay JF, Enikolopov G, Fernandes KJ, Jasmin JF, Calderone A. Cardiac resident nestin(+) cells participate in reparative vascularisation. Journal of Cellular Physiology. 228: 1844-53. PMID 23459851 DOI: 10.1002/jcp.24345  0.36
2012 Mercier I, Camacho J, Titchen K, Gonzales DM, Quann K, Bryant KG, Molchansky A, Milliman JN, Whitaker-Menezes D, Sotgia F, Jasmin JF, Schwarting R, Pestell RG, Blagosklonny MV, Lisanti MP. Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug. The American Journal of Pathology. 181: 278-93. PMID 22698676 DOI: 10.1016/j.ajpath.2012.03.017  0.36
2012 Wang Y, Wang X, Jasmin JF, Lau WB, Li R, Yuan Y, Yi W, Chuprun K, Lisanti MP, Koch WJ, Gao E, Ma XL. Essential role of caveolin-3 in adiponectin signalsome formation and adiponectin cardioprotection. Arteriosclerosis, Thrombosis, and Vascular Biology. 32: 934-42. PMID 22328772 DOI: 10.1161/ATVBAHA.111.242164  0.36
2012 Tsai EJ, Liu Y, Koitabashi N, Bedja D, Danner T, Jasmin JF, Lisanti MP, Friebe A, Takimoto E, Kass DA. Pressure-overload-induced subcellular relocalization/oxidation of soluble guanylyl cyclase in the heart modulates enzyme stimulation Circulation Research. 110: 295-303. PMID 22095726 DOI: 10.1161/CIRCRESAHA.111.259242  0.36
2011 Chi Y, Min J, Jasmin JF, Lisanti MP, Chang YT, Schuster VL. Development of a high-affinity inhibitor of the prostaglandin transporter. The Journal of Pharmacology and Experimental Therapeutics. 339: 633-41. PMID 21849625 DOI: 10.1124/jpet.111.181354  0.36
2011 de Almeida CJ, Witkiewicz AK, Jasmin JF, Tanowitz HB, Sotgia F, Frank PG, Lisanti MP. Caveolin-2-deficient mice show increased sensitivity to endotoxemia. Cell Cycle (Georgetown, Tex.). 10: 2151-61. PMID 21670588 DOI: 10.4161/cc.10.13.16234  0.36
2011 Bryant KG, Camacho J, Jasmin JF, Wang C, Addya S, Casimiro MC, Fortina P, Balasubramaniam S, Knudsen KE, Schwarting R, Lisanti MP, Mercier I. Caveolin-1 overexpression enhances androgen-dependent growth and proliferation in the mouse prostate. The International Journal of Biochemistry & Cell Biology. 43: 1318-29. PMID 21601007 DOI: 10.1016/j.biocel.2011.04.019  0.36
2011 Sharma A, Trane A, Yu C, Jasmin JF, Bernatchez P. Amlodipine increases endothelial nitric oxide release by modulating binding of native eNOS protein complex to caveolin-1 European Journal of Pharmacology. 659: 206-212. PMID 21463621 DOI: 10.1016/j.ejphar.2011.03.028  0.36
2011 Feiner EC, Chung P, Jasmin JF, Zhang J, Whitaker-Menezes D, Myers V, Song J, Feldman EW, Funakoshi H, Degeorge BR, Yelamarty RV, Koch WJ, Lisanti MP, McTiernan CF, Cheung JY, et al. Left ventricular dysfunction in murine models of heart failure and in failing human heart is associated with a selective decrease in the expression of caveolin-3. Journal of Cardiac Failure. 17: 253-63. PMID 21362533 DOI: 10.1016/j.cardfail.2010.10.008  0.36
2011 Jasmin JF, Rengo G, Lymperopoulos A, Gupta R, Eaton GJ, Quann K, Gonzales DM, Mercier I, Koch WJ, Lisanti MP. Caveolin-1 deficiency exacerbates cardiac dysfunction and reduces survival in mice with myocardial infarction. American Journal of Physiology. Heart and Circulatory Physiology. 300: H1274-81. PMID 21297026 DOI: 10.1152/ajpheart.01173.2010  0.36
2010 Ratliff BB, Singh N, Yasuda K, Park HC, Addabbo F, Ghaly T, Rajdev M, Jasmin JF, Plotkin M, Lisanti MP, Goligorsky MS. Mesenchymal stem cells, used as bait, disclose tissue binding sites: A tool in the search for the niche? American Journal of Pathology. 177: 873-883. PMID 20558574 DOI: 10.2353/ajpath.2010.090984  0.36
2009 Jasmin JF, Yang M, Iacovitti L, Lisanti MP. Genetic ablation of caveolin-1 increases neural stem cell proliferation in the subventricular zone (SVZ) of the adult mouse brain Cell Cycle. 8: 3978-3983. PMID 19923909  0.36
2009 Witkiewicz AK, Casimiro MC, Dasgupta A, Mercier I, Wang C, Bonuccelli G, Jasmin JF, Frank PG, Pestell RG, Kleer CG, Sotgia F, Lisanti MP. Towards a new "stromal-based" classification system for human breast cancer prognosis and therapy. Cell Cycle (Georgetown, Tex.). 8: 1654-8. PMID 19448435  0.36
2009 Mercier I, Bryant KG, Sotgia F, Bonuccelli G, Witkiewicz AK, Dasgupta A, Jasmin JF, Pestell RG, Lisanti MP. Using Caveolin-1 epithelial immunostaining patterns to stratify human breast cancer patients and predict the Caveolin-1 (P132L) mutation Cell Cycle. 8: 1396-1401. PMID 19342880  0.36
2009 Mercier I, Casimiro MC, Zhou J, Wang C, Plymire C, Bryant KG, Daumer KM, Sotgia F, Bonuccelli G, Witkiewicz AK, Lin J, Tran TH, Milliman J, Frank PG, Jasmin JF, et al. Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions. The American Journal of Pathology. 174: 1172-90. PMID 19342371 DOI: 10.2353/ajpath.2009.080882  0.36
2009 Mercier I, Jasmin JF, Pavlides S, Minetti C, Flomenberg N, Pestell RG, Frank PG, Sotgia F, Lisanti MP. Clinical and translational implications of the caveolin gene family: lessons from mouse models and human genetic disorders. Laboratory Investigation; a Journal of Technical Methods and Pathology. 89: 614-23. PMID 19333235 DOI: 10.1038/labinvest.2009.23  0.36
2008 Del Galdo F, Sotgia F, de Almeida CJ, Jasmin JF, Musick M, Lisanti MP, Jiménez SA. Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis. Arthritis and Rheumatism. 58: 2854-65. PMID 18759267 DOI: 10.1002/art.23791  0.36
2008 Mercier I, Vuolo M, Jasmin JF, Medina CM, Williams M, Mariadason JM, Qian H, Xue X, Pestell RG, Lisanti MP, Kitsis RN. ARC (apoptosis repressor with caspase recruitment domain) is a novel marker of human colon cancer Cell Cycle. 7: 1640-1647. PMID 18469522  0.36
2008 Mercier I, Casimiro MC, Wang C, Rosenberg AL, Quong J, Minkeu A, Allen KG, Danilo C, Sotgia F, Bonuccelli G, Jasmin JF, Xu H, Bosco E, Aronow B, Witkiewicz A, et al. Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation: Implications for the response to hormonal therapy Cancer Biology and Therapy. 7: 1212-1225. PMID 18458534  0.36
2008 Gioiosa L, Raggi C, Ricceri L, Jasmin JF, Frank PG, Capozza F, Lisanti MP, Alleva E, Sargiacomo M, Laviola G. Altered emotionality, spatial memory and cholinergic function in caveolin-1 knock-out mice. Behavioural Brain Research. 188: 255-62. PMID 18083242 DOI: 10.1016/j.bbr.2007.11.002  0.36
2007 Jasmin JF, Malhotra S, Singh Dhallu M, Mercier I, Rosenbaum DM, Lisanti MP. Caveolin-1 deficiency increases cerebral ischemic injury. Circulation Research. 100: 721-9. PMID 17293479 DOI: 10.1161/01.RES.0000260180.42709.29  0.36
2006 Jasmin JF, Mercier I, Dupuis J, Tanowitz HB, Lisanti MP. Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy Circulation. 114: 912-920. PMID 16940204 DOI: 10.1161/CIRCULATIONAHA.106.634709  0.36
2006 Lefebvre F, Préfontaine A, Calderone A, Caron A, Jasmin JF, Villeneuve L, Dupuis J. Modification of the pulmonary renin-angiotensin system and lung structural remodelling in congestive heart failure Clinical Science. 111: 217-224. PMID 16640505 DOI: 10.1042/CS20060027  0.36
2006 Jasmin JF, Mercier I, Sotgia F, Lisanti MP. SOCS proteins and caveolin-1 as negative regulators of endocrine signaling Trends in Endocrinology and Metabolism. 17: 150-158. PMID 16616514 DOI: 10.1016/j.tem.2006.03.007  0.36
2004 Jasmin JF, Mercier I, Hnasko R, Cheung MW, Tanowitz HB, Dupuis J, Lisanti MP. Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expression. Cardiovascular Research. 63: 747-55. PMID 15306231 DOI: 10.1016/j.cardiores.2004.05.018  0.36
2004 Hassan GS, Jasmin JF, Schubert W, Frank PG, Lisanti MP. Caveolin-1 deficiency stimulates neointima formation during vascular injury. Biochemistry. 43: 8312-21. PMID 15222744 DOI: 10.1021/bi049609t  0.36
2004 Jasmin JF, Dupuis J. Evaluation of Luminal Endothelin-Converting Enzyme Activity in the Pulmonary and Coronary Circulations Journal of Cardiovascular Pharmacology. 43: 21-25. PMID 14668563 DOI: 10.1097/00005344-200401000-00004  0.36
2003 Jasmin JF, Cernacek P, Dupuis J. Activation of the right ventricular endothelin (ET) system in the monocrotaline model of pulmonary hypertension: Response to chronic ET A receptor blockade Clinical Science. 105: 647-653. PMID 12823096 DOI: 10.1042/CS20030139  0.36
2003 Jasmin JF, Calderone A, Leung TK, Villeneuve L, Dupuis J. Lung structural remodeling and pulmonary hypertension after myocardial infarction: complete reversal with irbesartan. Cardiovascular Research. 58: 621-31. PMID 12798435 DOI: 10.1016/S0008-6363(03)00290-6  0.36
2001 Lucas M, Jasmin JF, Dupuis J. Effect of ETA receptor antagonist on pulmonary hypertension and vascular reactivity in rats with congestive heart failure Pulmonary Pharmacology and Therapeutics. 14: 307-314. PMID 11440559 DOI: 10.1006/pupt.2001.0298  0.36
2001 Jasmin JF, Lucas M, Cernacek P, Dupuis J. Effectiveness of a nonselective ETA/B and a selective ETA antagonist in rats with monocrotaline-induced pulmonary hypertension Circulation. 103: 314-318. PMID 11208695  0.36
2000 Dupuis J, Jasmin JF, Prié S, Cernacek P. Importance of local production of endothelin-1 and of the ET(B) receptor in the regulation of pulmonary vascular tone Pulmonary Pharmacology and Therapeutics. 13: 135-140. PMID 10873551 DOI: 10.1006/pupt.2000.0242  0.36
Show low-probability matches.